A retrospective, cohort study comparing all-cause inpatient hospitalizations in patients with dual diagnoses of schizophrenia and bipolar disorder who underwent treatment with long-acting injectable antipsychotics such as aripiprazole, haloperidol, paliperidone, and risperidone

Trial Profile

A retrospective, cohort study comparing all-cause inpatient hospitalizations in patients with dual diagnoses of schizophrenia and bipolar disorder who underwent treatment with long-acting injectable antipsychotics such as aripiprazole, haloperidol, paliperidone, and risperidone

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 May 2017

At a glance

  • Drugs Aripiprazole (Primary) ; Haloperidol; Paliperidone; Risperidone
  • Indications Bipolar disorders; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
    • 24 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top